MEDICOX Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was KRW 81.06 million compared to negative sales of KRW 0.00032 million a year ago. Net loss was KRW 42,618.62 million compared to KRW 23,934.53 million a year ago.

Basic loss per share from continuing operations was KRW 2,018 compared to KRW 1,808 a year ago. Diluted loss per share from continuing operations was KRW 2,018 compared to KRW 1,808 a year ago. Basic loss per share was KRW 2,018 compared to KRW 1,808 a year ago.